A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831

Clinical trial NCT03538522 · COMPLETED

Trial details

NCT number: NCT03538522
Sponsor: Biomed Industries, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Alzheimer Disease Alzheimer Dementia Dementia, Vascular Dementia With Lewy Bodies Cognitive Impairment Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Cognitive Disorder

Start date: 2018-09-15
Primary completion: 2019-09-30
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.